Skip to main content
. 2017 May 1;18(5):952. doi: 10.3390/ijms18050952

Figure 8.

Figure 8

(A) Inactivation of human liver microsomal formation of N-desethylamodiaquine from amodiaquine by various fargesin concentrations; (B) The relationship between the observed k (kobs) and fargesin concentration for the estimation of the Ki and kinact values of CYP2C8-catalyzed amodiaquine N-deethylation; (C) Inactivation of human liver microsomal formation of 4′-hydroxy-[S]-mephenytoin from [S]-mephenytoin by various fargesin concentrations; (D) The relationship between kobs and fargesin concentration for the estimation of the Ki and kinact values of CYP2C19-catalyzed [S]-mephenytoin 4′-hydroxylation; (E) Inactivation of human liver microsomal formation of 1′-hydroxymidazolam from midazolam by various fargesin concentrations; and (F) The relationship between the kobs and fargesin concentration for the estimation of the Ki and kinact values of CYP3A4-catalyzed midazolam 1′-hydroxylation.